Skip to main content
. 2016 Dec 5;15(1):97–102. doi: 10.3892/mmr.2016.5980

Figure 2.

Figure 2.

Effect of BBR on IL-17 expression in CD4+ T cells. In the presence of BBR, the expression of IL-17 in CD4+ T cells from HCs (n=6) and patients with active OBD (n=6) was significantly reduced compared with DMSO-treated cells. Data are presented as the mean ± standard deviation. BBR, berberine; IL-17, interleukin 17; HC, healthy control; OBD, ocular Behcet's disease; DMSO, dimethyl sulfoxide.